20-62324150-C-T

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_005560.6(LAMA5):​c.5698G>A​(p.Val1900Met) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.683 in 1,556,012 control chromosomes in the GnomAD database, including 364,673 homozygotes. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.65 ( 32341 hom., cov: 28)
Exomes 𝑓: 0.69 ( 332332 hom. )

Consequence

LAMA5
NM_005560.6 missense

Scores

2
16

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:3

Conservation

PhyloP100: 0.328

Publications

45 publications found
Variant links:
Genes affected
LAMA5 (HGNC:6485): (laminin subunit alpha 5) This gene encodes one of the vertebrate laminin alpha chains. Laminins, a family of extracellular matrix glycoproteins, are the major noncollagenous constituent of basement membranes. They have been implicated in a wide variety of biological processes including cell adhesion, differentiation, migration, signaling, neurite outgrowth and metastasis. Laminins are composed of 3 non identical chains: laminin alpha, beta and gamma (formerly A, B1, and B2, respectively) and they form a cruciform structure consisting of 3 short arms, each formed by a different chain, and a long arm composed of all 3 chains. Each laminin chain is a multidomain protein encoded by a distinct gene. The protein encoded by this gene is the alpha-5 subunit of of laminin-10 (laminin-511), laminin-11 (laminin-521) and laminin-15 (laminin-523). [provided by RefSeq, Jun 2013]
LAMA5 Gene-Disease associations (from GenCC):
  • nephrotic syndrome, IIa 26
    Inheritance: AR Classification: STRONG, MODERATE Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics
  • LAMA5-related multisystemic syndrome
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=2.248138E-6).
BP6
Variant 20-62324150-C-T is Benign according to our data. Variant chr20-62324150-C-T is described in ClinVar as Benign. ClinVar VariationId is 1250556.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.754 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
LAMA5NM_005560.6 linkc.5698G>A p.Val1900Met missense_variant Exon 43 of 80 ENST00000252999.7 NP_005551.3 O15230-1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
LAMA5ENST00000252999.7 linkc.5698G>A p.Val1900Met missense_variant Exon 43 of 80 1 NM_005560.6 ENSP00000252999.3 O15230-1
LAMA5ENST00000464134.1 linkn.486G>A non_coding_transcript_exon_variant Exon 2 of 3 2

Frequencies

GnomAD3 genomes
AF:
0.653
AC:
97611
AN:
149454
Hom.:
32333
Cov.:
28
show subpopulations
Gnomad AFR
AF:
0.539
Gnomad AMI
AF:
0.767
Gnomad AMR
AF:
0.717
Gnomad ASJ
AF:
0.752
Gnomad EAS
AF:
0.774
Gnomad SAS
AF:
0.638
Gnomad FIN
AF:
0.648
Gnomad MID
AF:
0.706
Gnomad NFE
AF:
0.692
Gnomad OTH
AF:
0.684
GnomAD2 exomes
AF:
0.683
AC:
138439
AN:
202720
AF XY:
0.684
show subpopulations
Gnomad AFR exome
AF:
0.531
Gnomad AMR exome
AF:
0.741
Gnomad ASJ exome
AF:
0.747
Gnomad EAS exome
AF:
0.781
Gnomad FIN exome
AF:
0.657
Gnomad NFE exome
AF:
0.689
Gnomad OTH exome
AF:
0.698
GnomAD4 exome
AF:
0.686
AC:
965300
AN:
1406438
Hom.:
332332
Cov.:
40
AF XY:
0.685
AC XY:
478209
AN XY:
698236
show subpopulations
African (AFR)
AF:
0.541
AC:
16357
AN:
30248
American (AMR)
AF:
0.734
AC:
21216
AN:
28900
Ashkenazi Jewish (ASJ)
AF:
0.746
AC:
17431
AN:
23354
East Asian (EAS)
AF:
0.775
AC:
29822
AN:
38460
South Asian (SAS)
AF:
0.636
AC:
49582
AN:
77968
European-Finnish (FIN)
AF:
0.659
AC:
33856
AN:
51380
Middle Eastern (MID)
AF:
0.716
AC:
3965
AN:
5536
European-Non Finnish (NFE)
AF:
0.689
AC:
752911
AN:
1092718
Other (OTH)
AF:
0.694
AC:
40160
AN:
57874
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.492
Heterozygous variant carriers
0
16316
32631
48947
65262
81578
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
19446
38892
58338
77784
97230
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.653
AC:
97648
AN:
149574
Hom.:
32341
Cov.:
28
AF XY:
0.652
AC XY:
47501
AN XY:
72826
show subpopulations
African (AFR)
AF:
0.538
AC:
21914
AN:
40698
American (AMR)
AF:
0.717
AC:
10687
AN:
14912
Ashkenazi Jewish (ASJ)
AF:
0.752
AC:
2608
AN:
3468
East Asian (EAS)
AF:
0.775
AC:
3933
AN:
5078
South Asian (SAS)
AF:
0.638
AC:
2735
AN:
4286
European-Finnish (FIN)
AF:
0.648
AC:
6727
AN:
10382
Middle Eastern (MID)
AF:
0.711
AC:
209
AN:
294
European-Non Finnish (NFE)
AF:
0.692
AC:
46740
AN:
67510
Other (OTH)
AF:
0.687
AC:
1405
AN:
2046
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
1662
3324
4986
6648
8310
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
774
1548
2322
3096
3870
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.685
Hom.:
73911
Bravo
AF:
0.655
TwinsUK
AF:
0.695
AC:
2576
ALSPAC
AF:
0.686
AC:
2643
ESP6500AA
AF:
0.543
AC:
2384
ESP6500EA
AF:
0.701
AC:
5993
ExAC
AF:
0.679
AC:
81754
Asia WGS
AF:
0.704
AC:
2448
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:3
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

May 04, 2021
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.11
BayesDel_addAF
Benign
-0.55
T
BayesDel_noAF
Benign
-0.42
CADD
Benign
12
DANN
Uncertain
1.0
DEOGEN2
Benign
0.033
T
Eigen
Benign
-0.42
Eigen_PC
Benign
-0.56
FATHMM_MKL
Benign
0.19
N
LIST_S2
Benign
0.45
T
MetaRNN
Benign
0.0000022
T
MetaSVM
Benign
-0.99
T
MutationAssessor
Benign
2.0
M
PhyloP100
0.33
PrimateAI
Benign
0.46
T
PROVEAN
Benign
-0.99
N
REVEL
Benign
0.064
Sift
Benign
0.18
T
Sift4G
Uncertain
0.059
T
Polyphen
0.84
P
Vest4
0.061
ClinPred
0.0057
T
GERP RS
2.0
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.0
Varity_R
0.035
gMVP
0.11
Mutation Taster
=92/8
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs2427283; hg19: chr20-60899206; COSMIC: COSV53352330; COSMIC: COSV53352330; API